Nephrology

A large-scale study in Taiwan has revealed that SGLT2 inhibitors significantly lower the risk of kidney failure in patients with Type 2 diabetes and CKD stage 5.

A new study from the University of Minnesota suggests that differences in how kidney function is measured in living kidney donors could have significant long-term implications.

A study using data from the SPRINT trial has linked even mild, reversible acute kidney injury (AKI) to a significantly higher risk of dementia and mild cognitive impairment (MCI) in older adults with cardiovascular risk factors.

A study has shown that controlling blood pressure through active ultrafiltration rather than antihypertensive drugs significantly improves survival rates among CKD patients undergoing hemodialysis or hemodiafiltration.

A new therapy combining daratumumab and tocilizumab offers hope for kidney transplant patients battling late antibody-mediated rejection.

Intensive blood pressure control reduces cardiovascular risks in CKD patients but may increase adverse events, new real-world study shows.

Neutrophil-to-lymphocyte ratio predicts early mortality in older dialysis patients, offering insights for personalised treatment planning.

Alpha blockers increase fracture risk in female CKD patients treated for voiding dysfunction, emphasising the need for cautious prescribing.